Risk of Nephrogenic Systemic Fibrosis in Stage 4 and 5 Chronic Kidney Disease Following Group II Gadolinium-based Contrast Agent Administration: Subanalysis by Chronic Kidney Disease Stage
Author(s) -
Prasad R. Shankar,
Matthew S. Davenport
Publication year - 2020
Publication title -
radiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.118
H-Index - 295
eISSN - 1527-1315
pISSN - 0033-8419
DOI - 10.1148/radiol.2020201492
Subject(s) - medicine , nephrogenic systemic fibrosis , kidney disease , gadolinium , stage (stratigraphy) , fibrosis , kidney , disease , pathology , paleontology , materials science , metallurgy , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom